Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed May 14, 2018 · 10-Q · 44 days after period end · 0001193125-18-161661
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Net Income | -$190.79K | -$3.96M | -$3.33M | -$2.77M |
| EPS Diluted | -$0.03 | -$0.15 | -$0.13 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 14, 2018 · 44 d after period end
